Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Change in Cash: 2017-2020

Historic Change in Cash for Monopar Therapeutics (MNPR) over the last 4 years, with Sep 2020 value amounting to $5.4 million.

  • Monopar Therapeutics' Change in Cash rose 955.75% to $5.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $13.5 million, marking a year-over-year increase of 531.80%. This contributed to the annual value of $38.6 million for FY2024, which is 4289.72% up from last year.
  • As of Q3 2020, Monopar Therapeutics' Change in Cash stood at $5.4 million, which was up 11,874.16% from -$46,173 recorded in Q2 2020.
  • Monopar Therapeutics' Change in Cash's 5-year high stood at $8.7 million during Q4 2019, with a 5-year trough of -$1.0 million in Q1 2019.
  • Moreover, its 3-year median value for Change in Cash was -$635,288 (2019), whereas its average is $745,522.
  • Per our database at Business Quant, Monopar Therapeutics' Change in Cash tumbled by 219.21% in 2018 and then skyrocketed by 1,301.86% in 2019.
  • Quarterly analysis of 4 years shows Monopar Therapeutics' Change in Cash stood at -$806,020 in 2017, then grew by 9.99% to -$725,493 in 2018, then spiked by 1,301.86% to $8.7 million in 2019, then skyrocketed by 955.75% to $5.4 million in 2020.
  • Its Change in Cash was $5.4 million in Q3 2020, compared to -$46,173 in Q2 2020 and -$621,567 in Q1 2020.